Follow the Nuo Therapeutics, Inc. stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Operating in the Health Care sector, Nuo Therapeutics, Inc. has logged 32 insider filings. Market capitalisation: €53.3m. The latest transaction was filed on 31 August 2026 (Acquisition). Among the most active insiders: JORDEN DAVID EMERSON. All data is openly available.
32
Insider Decl.
n/a
Thresholds
€1m
8 ops.
Buy Volume
€303,263
2 ops.
Sell Volume
29Σ signal
Buys €1m€303,263 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,897 of 29,051 companies
34.2
score / 100
Value
26
Quality
42
FCF yld-2.1%
Earn yld-4.7%
EV/EBITDA·
ROE·
Gross mgn67%
Net mgn-76%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
62,500 shares@ US$2.0010.3% of flowCommon StockSEC:0001437749-23-022109:0
Canonical exit: 30 Oct 2023 (T+90)
25 of 32 declarations
About Nuo Therapeutics, Inc.
Nuo Therapeutics, Inc. is a biotechnology company focused on developing treatments for chronic diseases. It aims to provide innovative solutions to enhance patient health.